Skip to main content

Retail Clinics

  • PL Developments to sell, distribute store-brand generic Zegerid OTC

    WESTBURY, N.Y. — PL Developments on Monday announced that it has acquired the exclusive rights to sell and distribute store-brand over-the-counter versions of omeprazole sodium bicarbonate capsules, the generic version of Merck’s Zegerid OTC.

    Par Pharmaceutical currently has approval for the prescription product and has filed for the OTC version. Upon FDA approval and upon favorable resolution of intellectual property litigation, PL Developments will begin marketing the new store-brand proton-pump inhibitor, the company stated.

  • Watson receives FDA approval for Nulecit

    MORRISTOWN, N.J. — The Food and Drug Administration has approved a generic treatment for iron deficiency anemia made by Watson Pharmaceuticals, Watson said Thursday.

    The drug maker announced the approval of Nulecit (sodium ferric gluconate complex in sucrose), an injectable and generic version of Sanofi-Aventis’ Ferrlecit.

    The drug is used to treat iron deficiency anemia in adults and children ages 6 years and older undergoing chronic hemodialysis and receiving supplemental epoetin therapy.

  • Report: Generic utilization can save Medicaid millions

    WASHINGTON — The American Enterprise Institute for Public Policy Research on Monday published a working paper that identified $329 million in overspending as a result of underutilization of generics.

    As total spending on 20 medicines with generic equivalents totaled approximately $1.5 billion, AEI concluded Medicaid overspent by 22% ($1.5 billion versus $1.17 billion) on these pharmaceuticals.

  • Healthcare exec joins Walmart

    BENTONVILLE, Ark. — Dijuana Lewis was named SVP healthcare solutions at Walmart, the company announced Thursday. She will report to John Agwunobi, who serves as president of Walmart’s health-and-wellness business unit.

  • Study: Sleep, relaxation can aid weight loss

    NEW YORK — The "battle of the bulge" can be won by adding sleep and relaxation to diet and exercise, according to a new study.

    Published in the International Journal of Obesity, a study conducted by Kaiser Permanente researchers found that among 472 obese participants with body mass indexes of 30 to 50, weight loss significantly correlated with decreased stress levels.

  • Prestige Brands introduces new allergy product

    IRVINGTON, N.Y. — Prestige Brands on Wednesday announced the launch of a new one-dose-per-day allergy medicine: PediaCare 24-Hour Allergy.

    "We listened to what the moms were looking for: a safe and effective allergy product for their children, ages 2 years and up, that works, has only one dose per day and tastes good," stated Sherry Polevoy, PediaCare senior brand manager. "Parents don't have to worry about redosing during the day, it's dye-free and it's a flavor that kids love: grape."

  • MyKidz Iron re-enters market

    MONMOUTH JUNCTION, N.J. — Tris Pharma on Tuesday announced its relaunch of the MyKidz Iron product line, which includes two supplement products and one prescription-only product.

    MyKidz Iron was launched in 2007 by NextWave Pharmaceuticals. In August 2010, NextWave partnered with Tris on developing medicines focused on the central nervous system. As part of that partnership, all non-CNS over-the-counter products were acquired by Tris.

  • Changing Medicare eligibility age shifts costs to employers, younger seniors

    MENLO PARK, Calif. — Raising Medicare’s eligibility age from 65 to 67 years in 2014 would generate an estimated $7.6 billion in net savings to the federal government, but also would result in an estimated net increase of $5.6 billion in out-of-pocket costs for 65- and 66-year-olds, as well as $4.5 billion in employer retiree healthcare costs, according to a new Kaiser Family Foundation projection of the potential change suggested by several deficit-reduction plans.

X
This ad will auto-close in 10 seconds